Tradestie Institutional Equity Comparison Engine

FXH vs FBT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FBT Overall Edge

FBT Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to First Trust NYSE Arca Biotechnology Index Fund (FBT) driven by superior Momentum & Technical, Options & Structure. Fundamentally, FXH trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus FBT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, FXH sits in UNCLASSIFIED (85th %ile IV; Dealer Gamma Walls on Pro) against FBT sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
FXH N/M vs FBT N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner FBT
1Y +21.8% vs +34.1% ยท 52W Pos 82% vs 84%
Options & Structure Winner FBT
UNCLASSIFIED (85th %ile IV) vs UNCLASSIFIED (4th %ile IV)
FXH NYSE Arca
First Trust Health Care AlphaDEX Fund
Institutional Equity
$136.68
-1.11% 1D
Market Cap N/A
1M Return +3.21%
1Y Return +21.77%
Forward P/E N/M
Unified AI Score
48.7 / 100 HOLD
Tech 42.0 Fund 44.0 Flow 50.0 Mom 31.1
FBT NYSE Arca
First Trust NYSE Arca Biotechnology Index Fund
Institutional Equity
$267.86
-1.17% 1D
Market Cap N/A
1M Return +1.61%
1Y Return +34.14%
Forward P/E N/M
Unified AI Score
50.3 / 100 HOLD
Tech 45.0 Fund 43.0 Flow 50.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FXH +21.77% FBT +34.14% Spread: +12.37 pp (FBT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FXH TTM Op. Margin: N/A FBT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FXH vs FBT. Trailing 12-month operating profitability (FXH N/A vs FBT N/A) and valuation multiples (FXH N/M vs FBT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FXH (1) vs FBT (2)
Institutional Metric FXH FBT Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 82% ($105โ€“$144) 84% ($189โ€“$283) Stronger Trend FBT
Beta / 30D Volatility Risk Regime 0.57ฮฒ ยท 25% Vol 0.79ฮฒ ยท 27% Vol Lower Realized Risk FXH
Unified Institutional Score Composite Signal 48.7 / 100 (HOLD) 50.3 / 100 (HOLD) Higher Composite FBT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FXH vs FBT Buy Guide
FXH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 85th %ile
IV Regime Extreme (>80th %ile)
Live FXH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FBT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live FBT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FXH nor FBT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.